We conclude that once metastatic lung disease has progressed to a late stage with tumor signal detectable throughout the tissue, monotherapy with either ICI or TNF-armed MYXV alone is insufficient to halt the disease, but combinatorial use of multi-dose virus/PBMCs plus ICI is significantly therapeutic and can result in significant disease regression and long-term survival. This evidence concerns the gene TNF and neoplasm.